MM-H&N were characterized by a diffuse (≥60% of neoplastic cells) nuclear expression of PRAME in 28 (77.8%) cases, and with a moderate/intense expression (intensity 2+ and 3+) in 20 (55.6%) (Figs. 3, 4). Here, PRAME is linked to Miyoshi myopathy.